エストラジオール経皮システムの世界市場動向・分析2018-2025

【英語タイトル】Global Estradiol Transdermal System Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D03569)・商品コード:QYR8D03569
・発行会社(調査会社):QYResearch
・発行日:2018年11月14日(※2024年版があります。お問い合わせください)
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、エストラジオール経皮システムの世界市場について調査・分析し、種類別には、0.025mg/日、0.0375mg/日、0.05mg/日、0.075mg/日、0.1mg/日に、用途別には、ホットフラッシュ、閉経後骨粗しょう症の予防、低エストロゲン症のトリートメント、中度から重度の血管運動症状、その他に区分してまとめました。調査対象企業は、Novartis、Allergan、Bayer、Noven Therapeutics、Mylan、Vertical Pharmaceuticals、Perrigo Pharma International等です。

・レポートの概要
・グローバル成長トレンド
・エストラジオール経皮システムの世界市場規模
・エストラジオール経皮システムの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別エストラジオール経皮システムの価格動向
・エストラジオール経皮システムの種類別市場規模(0.025mg/日、0.0375mg/日、0.05mg/日、0.075mg/日、0.1mg/日)
・エストラジオール経皮システムの用途別市場規模(ホットフラッシュ、閉経後骨粗しょう症の予防、低エストロゲン症のトリートメント、中度から重度の血管運動症状、その他)
・エストラジオール経皮システムの北米市場(アメリカ、カナダ、メキシコ)
・エストラジオール経皮システムのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・エストラジオール経皮システムのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・エストラジオール経皮システムの中南米市場(ブラジル等)
・エストラジオール経皮システムの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Novartis、Allergan、Bayer、Noven Therapeutics、Mylan、Vertical Pharmaceuticals、Perrigo Pharma International)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・エストラジオール経皮システムの市場規模予測
・エストラジオール経皮システムの種類別市場予測2018-2025(0.025mg/日、0.0375mg/日、0.05mg/日、0.075mg/日、0.1mg/日)
・エストラジオール経皮システムの用途別市場予測2018-2025(ホットフラッシュ、閉経後骨粗しょう症の予防、低エストロゲン症のトリートメント、中度から重度の血管運動症状、その他)
・エストラジオール経皮システムの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・エストラジオール経皮システムのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・エストラジオール経皮システムのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・エストラジオール経皮システムの中南米市場予測2018-2025(ブラジル等)
・エストラジオール経皮システムの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause. In 2018, the global Estradiol Transdermal System market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Estradiol Transdermal System.

This study researches the market size of Estradiol Transdermal System, presents the global Estradiol Transdermal System sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Estradiol Transdermal System in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Estradiol Transdermal System for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International

Market Segment by Product Type
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day

Market Segment by Application
Hot flashes
Prevention of postmenopausal osteoporosis
Treatment of hypoestrogenism
Moderate-to-severe vasomotor symptoms
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Estradiol Transdermal System status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Estradiol Transdermal System manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Estradiol Transdermal System are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Estradiol Transdermal System Market Size Growth Rate by Type
1.3.2 0.025 mg per day
1.3.3 0.0375 mg per day
1.3.4 0.05 mg per day
1.3.5 0.075 mg per day
1.3.6 0.1 mg per day
1.4 Market Segment by Application
1.4.1 Global Estradiol Transdermal System Market Share by Application (2018-2025)
1.4.2 Hot flashes
1.4.3 Prevention of postmenopausal osteoporosis
1.4.4 Treatment of hypoestrogenism
1.4.5 Moderate-to-severe vasomotor symptoms
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Estradiol Transdermal System Market Size
2.1.1 Global Estradiol Transdermal System Revenue 2013-2025
2.1.2 Global Estradiol Transdermal System Sales 2013-2025
2.2 Estradiol Transdermal System Growth Rate by Regions
2.2.1 Global Estradiol Transdermal System Sales by Regions 2013-2018
2.2.2 Global Estradiol Transdermal System Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Estradiol Transdermal System Sales by Manufacturers
3.1.1 Estradiol Transdermal System Sales by Manufacturers 2013-2018
3.1.2 Estradiol Transdermal System Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Estradiol Transdermal System Revenue by Manufacturers (2013-2018)
3.2.2 Estradiol Transdermal System Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Estradiol Transdermal System Market Concentration Ratio (CR5 and HHI)
3.3 Estradiol Transdermal System Price by Manufacturers
3.4 Key Manufacturers Estradiol Transdermal System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Estradiol Transdermal System Market
3.6 Key Manufacturers Estradiol Transdermal System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 0.025 mg per day Sales and Revenue (2013-2018)
4.1.2 0.0375 mg per day Sales and Revenue (2013-2018)
4.1.3 0.05 mg per day Sales and Revenue (2013-2018)
4.1.4 0.075 mg per day Sales and Revenue (2013-2018)
4.1.5 0.1 mg per day Sales and Revenue (2013-2018)
4.2 Global Estradiol Transdermal System Sales Market Share by Type
4.3 Global Estradiol Transdermal System Revenue Market Share by Type
4.4 Estradiol Transdermal System Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Estradiol Transdermal System Sales by Application

6 North America
6.1 North America Estradiol Transdermal System Breakdown Data by Company
6.2 North America Estradiol Transdermal System Breakdown Data by Type
6.3 North America Estradiol Transdermal System Breakdown Data by Application
6.4 North America Estradiol Transdermal System Breakdown Data by Countries
6.4.1 North America Estradiol Transdermal System Sales by Countries
6.4.2 North America Estradiol Transdermal System Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Estradiol Transdermal System Breakdown Data by Company
7.2 Europe Estradiol Transdermal System Breakdown Data by Type
7.3 Europe Estradiol Transdermal System Breakdown Data by Application
7.4 Europe Estradiol Transdermal System Breakdown Data by Countries
7.4.1 Europe Estradiol Transdermal System Sales by Countries
7.4.2 Europe Estradiol Transdermal System Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Estradiol Transdermal System Breakdown Data by Company
8.2 Asia Pacific Estradiol Transdermal System Breakdown Data by Type
8.3 Asia Pacific Estradiol Transdermal System Breakdown Data by Application
8.4 Asia Pacific Estradiol Transdermal System Breakdown Data by Countries
8.4.1 Asia Pacific Estradiol Transdermal System Sales by Countries
8.4.2 Asia Pacific Estradiol Transdermal System Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Estradiol Transdermal System Breakdown Data by Company
9.2 Central & South America Estradiol Transdermal System Breakdown Data by Type
9.3 Central & South America Estradiol Transdermal System Breakdown Data by Application
9.4 Central & South America Estradiol Transdermal System Breakdown Data by Countries
9.4.1 Central & South America Estradiol Transdermal System Sales by Countries
9.4.2 Central & South America Estradiol Transdermal System Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Estradiol Transdermal System Breakdown Data by Type
10.2 Middle East and Africa Estradiol Transdermal System Breakdown Data by Application
10.3 Middle East and Africa Estradiol Transdermal System Breakdown Data by Countries
10.3.1 Middle East and Africa Estradiol Transdermal System Sales by Countries
10.3.2 Middle East and Africa Estradiol Transdermal System Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.1.4 Estradiol Transdermal System Product Introduction
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.2.4 Estradiol Transdermal System Product Introduction
11.2.5 Allergan Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.3.4 Estradiol Transdermal System Product Introduction
11.3.5 Bayer Recent Development
11.4 Noven Therapeutics
11.4.1 Noven Therapeutics Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.4.4 Estradiol Transdermal System Product Introduction
11.4.5 Noven Therapeutics Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.5.4 Estradiol Transdermal System Product Introduction
11.5.5 Mylan Recent Development
11.6 Vertical Pharmaceuticals
11.6.1 Vertical Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.6.4 Estradiol Transdermal System Product Introduction
11.6.5 Vertical Pharmaceuticals Recent Development
11.7 Perrigo Pharma International
11.7.1 Perrigo Pharma International Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Estradiol Transdermal System
11.7.4 Estradiol Transdermal System Product Introduction
11.7.5 Perrigo Pharma International Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Estradiol Transdermal System Sales Channels
12.2.2 Estradiol Transdermal System Distributors
12.3 Estradiol Transdermal System Customers

13 Market Forecast
13.1 Global Estradiol Transdermal System Sales and Revenue Forecast 2018-2025
13.2 Global Estradiol Transdermal System Sales Forecast by Type
13.3 Global Estradiol Transdermal System Sales Forecast by Application
13.4 Estradiol Transdermal System Forecast by Regions
13.4.1 Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025
13.4.2 Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Estradiol Transdermal System Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Estradiol Transdermal System Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Estradiol Transdermal System Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Estradiol Transdermal System Product Picture
Table Estradiol Transdermal System Key Market Segments
Table Major Manufacturers Estradiol Transdermal System Covered in This Report
Table Global Estradiol Transdermal System Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Estradiol Transdermal System Sales Market Shar by Type 2013-2025
Figure 0.025 mg per day Figures
Table Major Manufacturers of 0.025 mg per day
Figure 0.0375 mg per day Figures
Table Major Manufacturers of 0.0375 mg per day
Figure 0.05 mg per day Figures
Table Major Manufacturers of 0.05 mg per day
Figure 0.075 mg per day Figures
Table Major Manufacturers of 0.075 mg per day
Figure 0.1 mg per day Figures
Table Major Manufacturers of 0.1 mg per day
Table Global Estradiol Transdermal System Market Share by Application 2018-2025 (K Units)
Figure Hot flashes Use Case
Figure Prevention of postmenopausal osteoporosis Use Case
Figure Treatment of hypoestrogenism Use Case
Figure Moderate-to-severe vasomotor symptoms Use Case
Figure Others Use Case
Figure Estradiol Transdermal System Report Years Considered
Figure Global Estradiol Transdermal System Market Size 2013-2025 (Million US$)
Figure Global Estradiol Transdermal System Sales 2013-2018 (K Units)
Table Global Estradiol Transdermal System Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Estradiol Transdermal System Sales by Regions 2013-2018 (K Units)
Table Global Estradiol Transdermal System Sales Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Sales Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Sales Market Share by Regions in 2018
Table Global Estradiol Transdermal System Revenue by Regions 2013-2018 (Million US$)
Table Global Estradiol Transdermal System Revenue Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Revenue Market Share by Regions 2013-2018
Figure Global Estradiol Transdermal System Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Estradiol Transdermal System Sales by Manufacturers (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Manufacturers (2013-2018)
Figure Global Estradiol Transdermal System Sales Share by Manufacturers in 2018
Table Estradiol Transdermal System Revenue by Manufacturers (2013-2018) (Million USD)
Table Estradiol Transdermal System Revenue Share by Manufacturers (2013-2018)
Figure Estradiol Transdermal System Value Share by Manufacturers in 2018
Table Global Estradiol Transdermal System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Estradiol Transdermal System Price (2013-2018) (USD/Unit)
Table Key Manufacturers Estradiol Transdermal System Plants/Factories Distribution
Table Key Manufacturers Estradiol Transdermal System Area Served
Table Date of Key Manufacturers Enter into Estradiol Transdermal System Market
Table Key Manufacturers Estradiol Transdermal System Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 0.025 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.0375 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.05 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.075 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 0.1 mg per day Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Sales Market Share by Type in 2017
Table Global Estradiol Transdermal System Revenue by Type (2013-2018) (Million US$)
Table Global Estradiol Transdermal System Revenue Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Revenue Market Share by Type (2013-2018)
Figure Global Estradiol Transdermal System Revenue Market Share by Type in 2017
Table Estradiol Transdermal System Price by Type 2013-2018 (USD/Unit)
Table Global Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Global Estradiol Transdermal System Sales Share by Application (2013-2018)
Figure Global Sales Estradiol Transdermal System Market Share by Application (2013-2018)
Figure Global Sales Estradiol Transdermal System Market Share by Application in 2017
Figure North America Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure North America Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table North America Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure North America Estradiol Transdermal System Sales Market Share by Company in 2018
Table North America Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure North America Estradiol Transdermal System Market Share by Type in 2018
Table North America Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure North America Estradiol Transdermal System Market Share by Application in 2018
Table North America Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table North America Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 North America Estradiol Transdermal System Sales Market Share by Countries
Table North America Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table North America Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Estradiol Transdermal System Revenue Market Share by Countries
Figure United States Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Canada Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Europe Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Europe Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Europe Estradiol Transdermal System Sales Market Share by Company in 2018
Table Europe Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Market Share by Type
Table Europe Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Market Share by Application
Table Europe Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Europe Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Estradiol Transdermal System Sales Market Share by Countries
Table Europe Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Europe Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure Europe Estradiol Transdermal System Revenue Market Share by Countries in 2018
Figure Germany Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure France Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure UK Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Italy Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Russia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Sales Market Share by Company in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Market Share by Type in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure Asia Pacific Estradiol Transdermal System Market Share by Application in 2018
Table Asia Pacific Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Estradiol Transdermal System Sales Market Share by Countries
Table Asia Pacific Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Estradiol Transdermal System Revenue Market Share by Countries
Figure China Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure China Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Japan Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Korea Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure India Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure India Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Australia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Estradiol Transdermal System Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Estradiol Transdermal System Sales by Company (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Company (2013-2018)
Figure Central & South America Estradiol Transdermal System Sales Market Share by Company in 2018
Table Central & South America Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure Central & South America Estradiol Transdermal System Market Share by Type in 2018
Table Central & South America Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure Central & South America Estradiol Transdermal System Market Share by Application in 2018
Table Central & South America Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure Central & South America Estradiol Transdermal System Sales Market Share by Countries in 2018
Table Central & South America Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure Central & South America Estradiol Transdermal System Revenue Market Share by Countries in 2018
Figure Brazil Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Estradiol Transdermal System Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Estradiol Transdermal System Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Estradiol Transdermal System Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Market Share by Type
Table Middle East and Africa Estradiol Transdermal System Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Market Share by Application
Table Middle East and Africa Estradiol Transdermal System Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Sales Market Share by Countries
Table Middle East and Africa Estradiol Transdermal System Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Estradiol Transdermal System Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Estradiol Transdermal System Revenue Market Share by Countries
Figure GCC Countries Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Estradiol Transdermal System Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Estradiol Transdermal System Revenue Growth Rate (2013-2018) (K Units)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Novartis Estradiol Transdermal System Sales Market Share in Global Market
Table Novartis Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Allergan Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Allergan Estradiol Transdermal System Sales Market Share in Global Market
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Bayer Estradiol Transdermal System Sales Market Share in Global Market
Table Bayer Recent Development
Table Noven Therapeutics Company Details
Table Noven Therapeutics Description and Business Overview
Table Noven Therapeutics Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Noven Therapeutics Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Noven Therapeutics Estradiol Transdermal System Sales Market Share in Global Market
Table Noven Therapeutics Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Mylan Estradiol Transdermal System Sales Market Share in Global Market
Table Mylan Recent Development
Table Vertical Pharmaceuticals Company Details
Table Vertical Pharmaceuticals Description and Business Overview
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales Market Share in Global Market
Table Vertical Pharmaceuticals Recent Development
Table Perrigo Pharma International Company Details
Table Perrigo Pharma International Description and Business Overview
Table Perrigo Pharma International Estradiol Transdermal System Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Perrigo Pharma International Estradiol Transdermal System Sales Growth Rate (2013-2018)
Table Perrigo Pharma International Estradiol Transdermal System Sales Market Share in Global Market
Table Perrigo Pharma International Recent Development
Figure Estradiol Transdermal System Value Chain
Table Estradiol Transdermal System Distributors List
Table Estradiol Transdermal System Customers List
Table Global Estradiol Transdermal System Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Revenue Forecast 2018-2025 (Million US$)
Table Global Estradiol Transdermal System Sales Forecast by Type 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Type 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Type 2018-2025
Table Global Estradiol Transdermal System Sales Forecast by Application 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Application 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Application 2018-2025
Table Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Estradiol Transdermal System Sales Market Share Forecast by Regions 2018-2025
Table Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Estradiol Transdermal System Revenue Market Share Forecast by Regions 2018-2025
Table North America Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table North America Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table North America Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure United States Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Canada Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure MexicoEstradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Europe Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Europe Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure France Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure UK Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Italy Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Russia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure China Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Japan Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Korea Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure India Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Australia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Indonesia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Thailand Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Malaysia Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Philippines Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Figure Vietnam Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Central & South America Estradiol Transdermal System Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Estradiol Transdermal System Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Estradiol Transdermal System Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Estradiol Transdermal System Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Estradiol Transdermal System Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Estradiol Transdermal System Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Estradiol Transdermal System Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Estradiol Transdermal System Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Estradiol Transdermal System Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Novartis、Allergan、Bayer、Noven Therapeutics、Mylan、Vertical Pharmaceuticals、Perrigo Pharma International

★調査レポート[エストラジオール経皮システムの世界市場動向・分析2018-2025] (コード:QYR8D03569)販売に関する免責事項を必ずご確認ください。
★調査レポート[エストラジオール経皮システムの世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆